Oppenheimer & Co. Inc. Has $1.32 Million Stock Position in Doximity, Inc. (NASDAQ:DOCS)

Oppenheimer & Co. Inc. decreased its holdings in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 24.5% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 22,720 shares of the company's stock after selling 7,388 shares during the quarter. Oppenheimer & Co. Inc.'s holdings in Doximity were worth $1,318,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of DOCS. Sanctuary Advisors LLC increased its stake in shares of Doximity by 10.2% during the 4th quarter. Sanctuary Advisors LLC now owns 7,251 shares of the company's stock worth $428,000 after purchasing an additional 672 shares during the last quarter. Truist Financial Corp acquired a new position in shares of Doximity during the 4th quarter worth $307,000. Global Retirement Partners LLC increased its stake in shares of Doximity by 468.1% during the 4th quarter. Global Retirement Partners LLC now owns 534 shares of the company's stock worth $29,000 after purchasing an additional 440 shares during the last quarter. IFP Advisors Inc increased its stake in shares of Doximity by 344.1% during the 4th quarter. IFP Advisors Inc now owns 1,328 shares of the company's stock worth $71,000 after purchasing an additional 1,029 shares during the last quarter. Finally, Amalgamated Bank increased its stake in shares of Doximity by 2.3% during the 4th quarter. Amalgamated Bank now owns 60,742 shares of the company's stock worth $3,243,000 after purchasing an additional 1,343 shares during the last quarter. Institutional investors and hedge funds own 87.19% of the company's stock.

Analyst Ratings Changes

Several brokerages have recently commented on DOCS. Truist Financial dropped their price target on shares of Doximity from $58.00 to $52.00 and set a "hold" rating on the stock in a research note on Friday, May 16th. JPMorgan Chase & Co. lowered their target price on shares of Doximity from $63.00 to $60.00 and set a "neutral" rating on the stock in a research note on Tuesday, May 27th. Mizuho lowered their target price on shares of Doximity from $65.00 to $60.00 and set a "neutral" rating on the stock in a research note on Friday, May 16th. KeyCorp lowered their target price on shares of Doximity from $83.00 to $70.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 16th. Finally, Bank of America raised their target price on shares of Doximity from $55.00 to $62.00 and gave the company a "neutral" rating in a research note on Wednesday. Eleven analysts have rated the stock with a hold rating, nine have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $63.11.

Doximity Stock Up 1.3%

Doximity stock traded up $0.78 during mid-day trading on Friday, reaching $61.19. The company had a trading volume of 4,819,229 shares, compared to its average volume of 2,172,364. Doximity, Inc. has a 52 week low of $25.00 and a 52 week high of $85.21. The company has a 50 day moving average of $56.21 and a 200-day moving average of $58.78. The firm has a market cap of $11.49 billion, a price-to-earnings ratio of 61.19, a PEG ratio of 4.10 and a beta of 1.33.

Doximity (NASDAQ:DOCS - Get Free Report) last released its quarterly earnings data on Thursday, May 15th. The company reported $0.38 EPS for the quarter, topping analysts' consensus estimates of $0.27 by $0.11. Doximity had a net margin of 36.60% and a return on equity of 21.75%. The firm's revenue was up 17.1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.25 earnings per share. On average, analysts predict that Doximity, Inc. will post 0.99 earnings per share for the current fiscal year.

Insider Transactions at Doximity

In related news, Director Timothy S. Cabral sold 10,000 shares of the stock in a transaction dated Wednesday, June 25th. The shares were sold at an average price of $60.00, for a total transaction of $600,000.00. Following the completion of the sale, the director now owns 6,360 shares in the company, valued at $381,600. This trade represents a 61.12% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Kira Scherer Wampler sold 2,000 shares of the stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $56.93, for a total transaction of $113,860.00. Following the sale, the director now owns 16,618 shares of the company's stock, valued at $946,062.74. This trade represents a 10.74% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 71,000 shares of company stock valued at $4,100,770. Company insiders own 37.40% of the company's stock.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.